*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

JYNA EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

Emtricitabine; Tenofovir Disoproxil Fumarate
200 mg; 300 mg
Tablet

ROA

Oral

Applicant Name

Jyna Pharma Ltd

NRN

C4-0479

Status

Active


ATC Code

J05AR03  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

 

Product Description

"EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE INDICATED IN ANTIRETROVIRAL COMBINATION THERAPY FOR THE TREATMENT OF HIV-1 INFECTED ADULTS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE ALSO INDICATED FOR THE TREATMENT OF HIV-1 INFECTED ADOLESCENTS, WITH NRTI RESISTANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS."

Manufacturer Name

Laurus Labs

Manufacturer Country

INDIA  

Approval Date

2021-05-07  

Expiry Date

2026-05-06